Progress in the management of thalassemia: Over a decade and a half of experience with subcutaneous desferrioxamine

Bone Marrow Transplantation

Volumn 19, Issue SUPPL. 2, 1997, Pages 9-10

  Giardina, P J ^a   Ehlers, K H ^a   Grady, R W ^a   Lesser, M L ^a   New, M I ^a   Hilgartner, M W ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; FERRITIN; HEMOGLOBIN; IRON;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CONFERENCE PAPER; DRUG INFUSION; ENDOCRINE FUNCTION; FERRITIN BLOOD LEVEL; HEART FUNCTION; HUMAN; IRON CHELATION; MAJOR CLINICAL STUDY; NEUROTOXICITY; PRIORITY JOURNAL; SPLENECTOMY; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; THALASSEMIA;

EID: 0030990996     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Ehlers, K.H., Giardina, P.J., Lesser, M.L, Engle, M.A., Hilgartner, M.W.: Improved Survival In Patients With Thalassemia Major On Desferrioxamine. J.Ped., 118: 540-545, 1991.
2. Giardina, P.J., Grady, R.W., Ehlers, K.H. Burstein, S., Graziano, J.H., Markenson, A.L., Hilgartner, M.W.: Current Therapy Of Cooley's Anemia: A Decade Of Experience With Subcutaneous Desferrioxamine. Ann N.Y. Acad Sci., 612: 286-292 1990.